For generations, the Klingenstein family has valued family involvement, patience and discipline, scientific research, measurable results, the advice of experts, and the joy that comes from helping make a difference in people’s lives.
Tackling important issues to benefit people
Klingenstein Philanthropies is committed to helping people by supporting breakthrough research in neuroscience, and by funding programs that improve the lives of children, especially in the fields of mental health, oral health, medicine, and education.
Disciplined commitments to our areas of focus
The areas we commit to are challenging and do not lend themselves to easy answers or quick fixes. They require patience and a long-term perspective. Once the decision has been made to get involved in a field, we tend to stay the course.
Current Funding Opportunities
We’re grateful for our partners in neuroscience, children’s health, and independent education. Please look through the current funding opportunities to see if there is an opportunity for us to work together.
Former Klingenstein-Simons Neuroscience Fellows become Gilliam Advisors
Congratulations to the Richard Daneman (2017-2020 Neuroscience Fellow) and John Tuthill (2016-2019 Neuroscience Fellow), each will be advising a 2022 HHMI Gilliam Fellow. Gilliam advisors are committed to helping graduate students from populations historically excluded and underrepresented in science realize their high potential. Learn more at HHMI News.
Previous Klingenstein Neuroscience Fellow Chairs Harvard Medical School’s Department of Neurobiology
David D. Ginty, Ph.D., recipient of a Klingenstein Neuroscience Award in 1995, has been named Chair of Harvard Medical School’s Department of Neurobiology. Dr. Ginty is the seventh chair to lead the department that includes 30 research laboratories that study neuroscience at the molecular, cellular, circuit, and systems levels, fueled by a commitment to address…
Past KTGF Fellow to Lead the Pittsburgh’s Psychiatry Research Pathway
Danella Hafeman, MD, PhD has been named director of the Psychiatry Research Pathway (PRP) for residents. The specialized PRP enables residents to simultaneously receive clinical training and pursue their passion for research through mentorship, conducting research projects, and receiving training that facilitates their career development into highly successful investigators. Read more about Dr. Hafeman’s new…
We wish to honor several generations of the Klingenstein family, past and present, as we bring together our longstanding areas of interest with our more recent work to improve the lives of those in need.